Technology
Health
Biopharmaceutical

Kala Pharmaceuticals

1,241

$8.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.22 (-2.45%) Today
$0.00 (0.00%) As of 6:35 PM EDT after-hours

Why Robinhood?

You can buy or sell KALA and other stocks, options, ETFs, and crypto commission-free!

About KALA

Kala Pharmaceuticals, Inc. Common Stock, also called Kala Pharmaceuticals, is a biopharmaceutical company. Read More It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.

CEO
Mark T. Iwicki
Employees
136
Headquarters
Watertown, Massachusetts
Founded
2009
Market Cap
454.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.21M
High Today
$9.05
Low Today
$8.46
Open Price
$9.00
Volume
910.13K
52 Week High
$9.66
52 Week Low
$3.24

Collections

Technology
Health
Biopharmaceutical
Therapy
Pharmaceutical
2017 IPO
US
North America

KALA Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, Pre-Market

People Also Bought

Novavax

38,640

$15.52

+11.98%

Novavax

38,640

$15.52

+11.98%

Viking Therapeutics

51,599

$4.40

-2.00%

Inovio

221,240

$7.68

+2.13%

ObsEva

2,243

$2.09

-3.24%

You May Also Like

AAXJ
FPRX
MBIO
PGM
UYG
CECE
RTMVY
TEAF
FRAF
FFG
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy KALA

Market Price$8.75
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell KALA stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up